1. Home
  2. OEC vs QTTB Comparison

OEC vs QTTB Comparison

Compare OEC & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$5.90

Market Cap

397.0M

Sector

Industrials

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$8.77

Market Cap

450.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OEC
QTTB
Founded
1862
2015
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.0M
450.1M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
OEC
QTTB
Price
$5.90
$8.77
Analyst Decision
Sell
Strong Buy
Analyst Count
4
1
Target Price
$6.56
★ $13.00
AVG Volume (30 Days)
344.7K
★ 569.6K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
★ 1.11%
N/A
EPS Growth
N/A
★ 136.78
EPS
★ N/A
N/A
Revenue
★ $1,806,700,000.00
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.21
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.35
$1.83
52 Week High
$8.64
$23.57

Technical Indicators

Market Signals
Indicator
OEC
QTTB
Relative Strength Index (RSI) 45.19 20.33
Support Level $5.61 $4.59
Resistance Level $6.57 $16.85
Average True Range (ATR) 0.25 0.61
MACD 0.04 -0.19
Stochastic Oscillator 44.06 1.23

Price Performance

Historical Comparison
OEC
QTTB

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: